CTOs on the Move

Stephen L. LaFrance Pharmacy d/b/a USA Drug

www.usadrug.com

 
Stephen L. LaFrance, a certified pharmacist, founded the USA Drug family in February 1968. The retail drug store chain now boasts over 110 retail outlets in Tennessee, Mississippi, Missouri, and Arkansas, branded as USA Drug, Super D Drugs and Ike's Deep
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.usadrug.com
  • 2100 Brookwood Dr
    Little Rock, AR USA 72202
  • Phone: 501.296.3300

Executives

Name Title Contact Details

Similar Companies

Country Doctor Community Health Centers

Country Doctor Community Health Centers is a non-profit 501(c)3 organization that maintains two clinic sites, Carolyn Downs Family Medical Center and Country Doctor Community Clinic. Since our founding, our primary goal has been to provide the highest

Texas American Title Company

Texas American Title Company is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Texas American Title Company, please visit www.texasamerican.com

MAQUET

MAQUET offers complete medical technology solutions for operating theatres and intensive care units, guaranteeing optimum treatment for patients and greatest-possible working comfort for personnel. MAQUET - The Gold Standard. To enter the MAQUET website

National Stroke Association

National Stroke Association is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.